ARCHIVES

Improved NCI Relations With FDA Cited As Model For Government Accord, Lasagna Committee Says

This article is from The Cancer Letter archive.

Vol. 16 No. 16 | April 20, 1990

Download PDF Visit The Full Archive

Related Articles

AZURE Trial: Zoledronic Acid Didn’t Improve DFS In Stage II/III

December 31, 2010

ACS Adopts ‘Measures of Success’ To Mark Progress T0 Yr. 2000

April 17, 1992

Group Chairmen Accept Most Changes In Terms Of Award, Object To CTEP Adjustments

December 2, 1988

Other News: ESAs Fail To Reduce Blood Transfusions, SEER Data Show

November 20, 2009

In Brief: One More Committee Review Needed for L.A., Rhode Island; Animal Tests In Factories (?)

May 13, 1977

Nine Cancer Act Changes Considered By NCAB Subcommittee

September 3, 1976